相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine
Tae Woo Park et al.
ADDICTION (2020)
Designer benzodiazepines' pharmacological effects and potencies: How to find the information
Souleiman El Balkhi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Fiammetta Cosci et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)
Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance
Francesco Paolo Busardo et al.
FORENSIC SCIENCE INTERNATIONAL (2019)
Designer Benzodiazepines: A Review of Published Data and Public Health Significance
H. Karl Greenblatt et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
An expanding world of new psychoactive substances-designer benzodiazepines
Jolanta B. Zawilska et al.
NEUROTOXICOLOGY (2019)
Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017
Joseph E. Carpenter et al.
CLINICAL TOXICOLOGY (2019)
Review: Adjunctive pharmacologic approaches for benzodiazepine tapers
Justine W. Welsh et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Our Other Prescription Drug Problem
Anna Lembke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays
Madeleine Pettersson Bergstrand et al.
DRUG TESTING AND ANALYSIS (2017)
Treatment of Benzodiazepine Dependence
Michael Soyka
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine
Madeleine Pettersson Bergstrand et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Overdose of Etizolam: The Abuse and Rise of a Benzodiazepine Analog
Charles W. O'Connell et al.
ANNALS OF EMERGENCY MEDICINE (2015)
Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial
Sallie J. Hadley et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)